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" diit,I;iilleO Willi" l i l l l l f "~p lex  corlgennat anomalies, The purpOSe of thil 
Study was to close MVSD's wflh modlhed Amplatz device which iS mthoval!io, 
self conteitrlg, rLe$~ltiorieblo and low prefilo< It is consthlcfe<l of 0004 inch 
Nltmol wire n~e,~h filled with polye~ler fibem 
Mettrods: MVSO W~S created in twelv~ ~ viii nghl tf~r~lon'ly wffh the 
help of a sham punch, T~ loca~<m w~ anterm¢ mu~ular (3), mldmusculat 
(4). apical (4) aeO a ~ r  cecal type in eee~ The ~=e of the 
m~ged ~ fl limit14 mm Thn~e of ~ ~ w~m closed mWaopem- 
~ ~ ~ of tt~ ca~tLaf thft:~Jgh t i~ l~lllt v~ritul~f l f~  waft. Tho 
~ d m  of ~ m~e VSO's were ~k~ed t!vee to six week~ post operatively 
irl ~ ctledia¢ Caiheit, lilaliee l.atx~elo~. ~ ~ wlm! ~ 
a 7 Fmnch ~eath ~ ,  T!aesesophagea! e~he~a~ wp 
~ed ~ eemal ~ 
Re~ld~ ~ was ~ m all ~ enter!It. The im~jate  
clomim rate was ! I  when the i was ~ inlraopemiitely The 
pa~utt~eo~ ck~mm rate was ~5% (5~) ~medtateht after i~acement of i~e 
~ ,  ~ (-i,~) allo~ oee ~ aed 100~o (~)  atter rn~se m0ntl~ O,e 
t!og ~e41~n~l a ae~i  ~ .  
~,~, -# i~-  "!]~S ~ ~rs  h=g~ly ~ ious  in ClOSing musculer 
V~n~f  ~ defects, ~ [! £-an be delivered With a small delivery 
!fhe-~,~, ,n~ i~ t ' ,~ml~,  m f ~  eftef ~ it will be highly suitable 
fo~ smali ci~lmen 
1069-1551 ~t~l l t  Closure oil SeWai Areal Detect= 
With the Amp~" Oe~k:e in Ch i ldm and 
Adults 
P-G. Biomstad ~ . F. BeigeF. 1. l~hnmt ~, E. ThauIow'. B. Smev~'. 
S .S .~ct i l sen ' .P  Ewml~,PE. Lan~ '#~kshosp#a/e£ TheNaimnal 
Hos~,  University el Os/o, ~ : ~ He~zentmm Bet'tin. 
Germany 
~Zql:~O~: The early restit~ frem ~ ~ m  centers Of get'cutaneol~/i m- 
te~Emlional closure of areal septai deleot (ASD) at ~ ~ fosse with the 
Amplalzer" detice are pmseofed. 
Ma~,na/and Me~ho~." The implantatmn of the Amptalzer" device was 
started and ~ m 34 patients wdh the age of 12-70 yearn mean 19.3 
_+ 22.1. ~ 8.1- The we=ght was 9.4-120 ~,g, tr~',...3n 39.4 ~ 2~.8. median 
23_8. The stretched ASD s~ze was 6-20 ram. mean t2.3 -~ 3.8, median 12 
ram, the flow ratios lrom 09-30:1. mean 2 0 ± 0.53. meatan 18. ca~cutateQ 
flora oxlmetric measurements. 
Resu/l~ A de~ce could be in~plenled in all cases without problems. 
No complication occurred, except for one transient disc thrombus, wti~-h 
resolved urmveeffully after additional hepaon Ireatreent. The fluoroscopy 
time was 10.7 ± 5.3 rain, median 9.3. The longest time Of 27.4 minutes 
occurred in the first patient. The intervenlional time was 45-180 rain., mean 
99 9 ± 30.3, median 95 On the morning following implantal]on, the ~,,ices 
were fouad to reream in correct position, A - 1 mm shunt was detected in 
one with color Doppler. Nedher venous inflow nor valves were affected aecl 
normalization of the seplal movement had already occurred. During up to 
one year's follow-up no adverse effect has been detected. The minimal shunt 
of less than 1 mm persists after 3 months 
ConclusiOn: Selecle¢l ASPs at the oval fossa can be closed easily, reliably 
and safely with the Amplatzer" dellce in all age groups. 
11069-156 t Repeat Balloon Dilation of Congenital Va..hrar 
Aortic Stenosis: Immediate Results and Mimerm 
Outcome 
G.M, Satou, S.B. Perry, J.E. Lock. J.F. Keane. Chi/dren's Hospital, Boston, 
Massachusetts. USA 
Balloon dilation (BD) is the primary treatment for the initial management of 
congenital valvar aorlic stenosis (CVAS) for pts of all ages at our institution. 
However, the preferred approach to restenosts follo~qng BD of CVAS remains 
unclear. In order to determine fficacy, we reviewed all a-ailable data on pts 
who unde~ent 2 or more BDs of CVAS between 1/85 and 12/96. Among 298 
pts (70 neonates), 37 underwent repeat BD, 3 of whom had a prior surgical 
valvotomy and 4 with hypoplastic left heart syndrome (HLHS). A greater 
proportion of neonates had a repeat BD (26% vs 8%, p < 0,001). At BD2 (1 
d-7.5 ym post BD1), the peak systolic ejection gradient was reduced from 66 
± 23 to 35 ± 16 mmHg (p < 0.001), Aortic regurgitation (AR) increased in 11 
pts (30%), and was moderate or more in 8 (22%). There was no procedure 
related mortality. 
During a mean follow-up of 5 yrs (10 mo- l l  yrs), there were 2 deaths, 1 
surgically related and 1 following withdrawal of support in apt with HLHS. Of 
the 35 survivors, 5 had operations for AS or AR and 2 pts had a Norwood 
procedure. Among the remaining 28 pts, 24 of 25 (96%) were asymptomatic, 
the maximum instantaneous Doppler gradient across the aortic valve was 50 
± 15 mmHg in 26 pts, and AR was moderate or more in 8 of 27 (30%) pts. 
Conclusions: 1 ) Repeat BD is f~ ib~,  effect re, a~d ~ ~a ~/2) 
AR was ill least mixleraf~ i~: ;~% of pie after BD2 3) Repeat E!I~ was rno~e 
common in those who h~d BI l l  as neonalt~s 
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BaOkgt1~im~i: Coil embolil-alton dunng PDA Closure ~ ~ ~ 
ppmem of comrotled ~ sy,tltms, Tl~s mpoet ~ ll~e etal~ ~ 
~ S  of ~ new commtle¢! mtes~ W!lem tel 0052 <' and 0.038" CO~ 
Meth~:  Tr~ ~ sy~!em wu ~ from ieexpemm#e 
core!fling of ~ guide wlm mat was I on!o l ! i  e~l of lhe G~uma 
=oq ~ng mf~a l  of the ce~f thmugi~ a ~ =healh The ~ wai released 
by a(P,anong ~ dirac11ona! Calibre! Over the g~dtM wire thereby 
the coil for deltvel,#. The ml t l~  of ,,:oil retneval and ~ was 
in vi~m< The 0052* contrelfed release ay=tem was m,~[~iue~ ~ in 6 
palients 1o Close large PDAa, Procedural results were ~red  with e cohort 
of 18 pa~ who ~(t  a t te~ed large PDA closure using uncOmrOfled co~l 
relea~ 
F~su~: In vtlm testing shoved IlXT~= sl~ce~lful mtnevai and retease 
Ot a lucy del~Oyed c(,I w~h the force requmd foe r~,iease >3 ~mes ft~ 
foi'ce requinf~l for relfleval (5.4 t- 20 vs. 1.4 ~ 0.4 N tot 0 .~ '  coils; 31 
t 08 ~ 1.0 ~ 0.3 N tm 0.038 co~ls) ,~x of 8 coe~ Cod release 
patmnts (I00%), ages 16 monlhs to 48 ym ~ PDA d im 4.! ± 0,7 
men~ bad succesMul ¢lesure wire no ~ of co~l embolizatmn, 
results compare favo~ lo the 11 of 16 uncontrolled cell rek~se ~ 
(69%), ages 3 monlhs re 43 yTs with PDA diameter 4.3 ± 0.6 ram, wtto 
successful closure. 
p , 005 
Release System En~o~l~l Rate" Procedute'time" Ruoro Time' Hosp Charges 
u~oeec i l l l l  32% 2~9 ~ 7n 64 ~ ~ 11470 ~ 3496 
Conlrolled(6) (T% 186 = 27 34 ¢ 16 9810 ~ 831 
Conclusion" The new 0.052-in cod release system is safe and effective 
for closing large PDAs. The 0.o38.m reteaso system may penvi~ ll~l~i I tm 
controlled closure of smaller PDAs and technically difficult penpheral vascular 
anomalies. Further clinical reals are warranted. 
I1069-158 [ Tmnscaiheter Occlusion Versus Surgery for 
Patent Ducllus Ar l ldosus :  A Five-Year 
Experience o f  Tm=tment Success, Hospital 
Course and Complications 
KL. Rosen. G.L. Rosenthal, R.G Gntt~, M.R Nihdl, C,E. Mullins, F.F Ing. 
Texas Ch#dren's ~ f ,  B~Wtor Col~ge of Medictne. Houston. Texas, USA 
Background: Cunent treatments for patent 0uofus arterlosus (PDA) include 
surgical ligalton/d~smn and t~nscatheler occlusion, The pt=rpose of this 
study was to compare treatment success, hosl~tal course arid COmplications 
following surgical versus ~the ler  trealment of isolated PDA, 
Methods: Hospital renords from 1/93 to 3/97 were retrospact~ely re- 
viewed. Com~catmns were defined as post-procedure vents which caused 
morbidity or prolonged hospitalization. Successful treatment was defined as 
no residual ductsl shunting on follow up echocardiogtam. 
ResulP3: Su~,~--=~ul treatmenl in the surgery patients was 47/48 (97.9%) 
and 106/114 (93.0%) in the catheterization patients (p = NS), Cathelenzation 
devices implanted were Giaofurco-Grilkca Vascular Occlusion Devices (19 
patients) and Gianturco Coils (95 patients). (PP.Post Pn~edure. ICU-tnten- 
swe Care Unit. CT.Chest Tube) 
tData = Means) AGE YRS v~R" KG PP DAYS ICU DAYS CT DAYS EFT HR:~ 
Surger~ 4 ~ 137 58 1 4 1 2 84 
C.ath 74 235 11 02 O0 00 
p-value 0013 0001 0001 0001 - 0001 • 0001 
At least one complication was found tn 19/48 (39.6%) surgical patients and 
91114 (7.9%) catheterization patients (p < 0.001). 
Conclusions: Tmnscathetor occlusion and surgery are equally effectwe 
1o treat PDA. When compared 1o surgical therapy, tmnscatheter occlusion is 
associated with significantly fewer complications, less morbidity and fewer 
post procedure hospital and ICU days. 
